Dr. Scott Gottlieb, who has served as FDA Commissioner since May 2017, has announced that he will be resigning from the agency. Dr. Gottlieb has previously voiced support for wider access to biosimilars.
See more »
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.
© Goodwin
Refine your interests »
